Chimeric M1/M2 muscarinic receptors

Correlation of ligand selectivity and functional coupling with structural modifications

J. Lai, L. Nunan, S. L. Waite, S. W. Ma, John W Bloom, William R Roeske, H. I. Yamamura

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Chimeric M1/M2 receptors were expressed in murine fibroblasts (B82) transfected with recombinant m1/m2 receptor genes. The binding affinities of a number of muscarinic antagonists and the agonist carbachol for these chimeric receptors were compared with the ligands' affinities for the M1 and M2 receptors expressed in the B82 cells. The tricyclic compounds, namely pirenzepine (PZ), 11-{[2-[(diethylamino)methyl]-1-piperidinyl]acetyl}-5,11- dihydro-6H-pyrido-[2,3-6][1,4]benzodiazepine-6-one (AF-DX 116) and himbacine, shared a binding site between transmembrane domains VI and VII. However, the selective interaction of pirenzepine with M1 and AF-DX 116 and himbacine with M2 involved different structural regions. The high-affinity binding for 4-diphenylacetoxy-N-methylpiperidine and hexahydrosiladifenidol was confined to within loop o2 and transmembrane domains V and VI, which were clearly distinguishable from those of the tricyclic compounds. These results support the hypothesis that the ligands' stereochemical features are critical in their optimal alignment within the ligand binding pocket. The cytoplasmic i3 loop modulated the binding of carbachol such that receptors which contained the i3 domain from the M2 receptor exhibited a single high-affinity state, whereas those with the i3 domain from the M1 receptor had an additional low- affinity state for the agonist. The i3 regions are essential for the differential functional coupling of the M1 and M2 receptors to second messenger systems; however, additional upstream regions seem to be essential for a potent and efficacious activation of phospholipase C by the M1 receptor. This study provides new insight into the molecular basis of ligand selectivity.

Original languageEnglish (US)
Pages (from-to)173-180
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume262
Issue number1
StatePublished - 1992

Fingerprint

Muscarinic M2 Receptors
Muscarinic M1 Receptors
Ligands
Pirenzepine
Carbachol
Muscarinic Agonists
Muscarinic Antagonists
Type C Phospholipases
Second Messenger Systems
Fibroblasts
Binding Sites
Genes
himbacine
otenzepad

ASJC Scopus subject areas

  • Pharmacology

Cite this

Chimeric M1/M2 muscarinic receptors : Correlation of ligand selectivity and functional coupling with structural modifications. / Lai, J.; Nunan, L.; Waite, S. L.; Ma, S. W.; Bloom, John W; Roeske, William R; Yamamura, H. I.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 262, No. 1, 1992, p. 173-180.

Research output: Contribution to journalArticle

@article{e04e8d584d5f4675a0a1d7c48d2021b1,
title = "Chimeric M1/M2 muscarinic receptors: Correlation of ligand selectivity and functional coupling with structural modifications",
abstract = "Chimeric M1/M2 receptors were expressed in murine fibroblasts (B82) transfected with recombinant m1/m2 receptor genes. The binding affinities of a number of muscarinic antagonists and the agonist carbachol for these chimeric receptors were compared with the ligands' affinities for the M1 and M2 receptors expressed in the B82 cells. The tricyclic compounds, namely pirenzepine (PZ), 11-{[2-[(diethylamino)methyl]-1-piperidinyl]acetyl}-5,11- dihydro-6H-pyrido-[2,3-6][1,4]benzodiazepine-6-one (AF-DX 116) and himbacine, shared a binding site between transmembrane domains VI and VII. However, the selective interaction of pirenzepine with M1 and AF-DX 116 and himbacine with M2 involved different structural regions. The high-affinity binding for 4-diphenylacetoxy-N-methylpiperidine and hexahydrosiladifenidol was confined to within loop o2 and transmembrane domains V and VI, which were clearly distinguishable from those of the tricyclic compounds. These results support the hypothesis that the ligands' stereochemical features are critical in their optimal alignment within the ligand binding pocket. The cytoplasmic i3 loop modulated the binding of carbachol such that receptors which contained the i3 domain from the M2 receptor exhibited a single high-affinity state, whereas those with the i3 domain from the M1 receptor had an additional low- affinity state for the agonist. The i3 regions are essential for the differential functional coupling of the M1 and M2 receptors to second messenger systems; however, additional upstream regions seem to be essential for a potent and efficacious activation of phospholipase C by the M1 receptor. This study provides new insight into the molecular basis of ligand selectivity.",
author = "J. Lai and L. Nunan and Waite, {S. L.} and Ma, {S. W.} and Bloom, {John W} and Roeske, {William R} and Yamamura, {H. I.}",
year = "1992",
language = "English (US)",
volume = "262",
pages = "173--180",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Chimeric M1/M2 muscarinic receptors

T2 - Correlation of ligand selectivity and functional coupling with structural modifications

AU - Lai, J.

AU - Nunan, L.

AU - Waite, S. L.

AU - Ma, S. W.

AU - Bloom, John W

AU - Roeske, William R

AU - Yamamura, H. I.

PY - 1992

Y1 - 1992

N2 - Chimeric M1/M2 receptors were expressed in murine fibroblasts (B82) transfected with recombinant m1/m2 receptor genes. The binding affinities of a number of muscarinic antagonists and the agonist carbachol for these chimeric receptors were compared with the ligands' affinities for the M1 and M2 receptors expressed in the B82 cells. The tricyclic compounds, namely pirenzepine (PZ), 11-{[2-[(diethylamino)methyl]-1-piperidinyl]acetyl}-5,11- dihydro-6H-pyrido-[2,3-6][1,4]benzodiazepine-6-one (AF-DX 116) and himbacine, shared a binding site between transmembrane domains VI and VII. However, the selective interaction of pirenzepine with M1 and AF-DX 116 and himbacine with M2 involved different structural regions. The high-affinity binding for 4-diphenylacetoxy-N-methylpiperidine and hexahydrosiladifenidol was confined to within loop o2 and transmembrane domains V and VI, which were clearly distinguishable from those of the tricyclic compounds. These results support the hypothesis that the ligands' stereochemical features are critical in their optimal alignment within the ligand binding pocket. The cytoplasmic i3 loop modulated the binding of carbachol such that receptors which contained the i3 domain from the M2 receptor exhibited a single high-affinity state, whereas those with the i3 domain from the M1 receptor had an additional low- affinity state for the agonist. The i3 regions are essential for the differential functional coupling of the M1 and M2 receptors to second messenger systems; however, additional upstream regions seem to be essential for a potent and efficacious activation of phospholipase C by the M1 receptor. This study provides new insight into the molecular basis of ligand selectivity.

AB - Chimeric M1/M2 receptors were expressed in murine fibroblasts (B82) transfected with recombinant m1/m2 receptor genes. The binding affinities of a number of muscarinic antagonists and the agonist carbachol for these chimeric receptors were compared with the ligands' affinities for the M1 and M2 receptors expressed in the B82 cells. The tricyclic compounds, namely pirenzepine (PZ), 11-{[2-[(diethylamino)methyl]-1-piperidinyl]acetyl}-5,11- dihydro-6H-pyrido-[2,3-6][1,4]benzodiazepine-6-one (AF-DX 116) and himbacine, shared a binding site between transmembrane domains VI and VII. However, the selective interaction of pirenzepine with M1 and AF-DX 116 and himbacine with M2 involved different structural regions. The high-affinity binding for 4-diphenylacetoxy-N-methylpiperidine and hexahydrosiladifenidol was confined to within loop o2 and transmembrane domains V and VI, which were clearly distinguishable from those of the tricyclic compounds. These results support the hypothesis that the ligands' stereochemical features are critical in their optimal alignment within the ligand binding pocket. The cytoplasmic i3 loop modulated the binding of carbachol such that receptors which contained the i3 domain from the M2 receptor exhibited a single high-affinity state, whereas those with the i3 domain from the M1 receptor had an additional low- affinity state for the agonist. The i3 regions are essential for the differential functional coupling of the M1 and M2 receptors to second messenger systems; however, additional upstream regions seem to be essential for a potent and efficacious activation of phospholipase C by the M1 receptor. This study provides new insight into the molecular basis of ligand selectivity.

UR - http://www.scopus.com/inward/record.url?scp=0026612960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026612960&partnerID=8YFLogxK

M3 - Article

VL - 262

SP - 173

EP - 180

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -